SOURCE: Implant Sciences

August 17, 2011 11:39 ET

Implant Sciences' CEO to Present at National Investment Banking Association Conference in Boston on August 18

WILMINGTON, MA--(Marketwire - Aug 17, 2011) - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced that its CEO, Glenn D. Bolduc, will present at the National Investment Banking Association Conference on August 18th at 12:20pm. The conference is taking place between August 17 and August 19 at the Omni Parker House Hotel in Boston.

Mr. Bolduc will discuss some of the challenges facing security professionals today and identify how Implant Sciences provides innovative solutions that address those challenges. He will also review the Company's recent developments and describe Implant Sciences' growth strategy for the future. Implant Sciences continues to experience increased revenues driven by sales of its explosives trace detection equipment through a global distribution network.

About the National Investment Banking Association

The National Investment Banking Association, Inc. (NIBA) is the only national not-for-profit trade association of regional and independent brokerages, investment banking firms, and related capital market service providers. Since its inception, NIBA member firms have successfully completed 1000+ equity offerings totaling approximately $10 billion in new capital for America's finest emerging growth companies. The member firms of NIBA represent over 8800 registered representatives and with an estimated $78BB assets under management.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 Portable Explosives Detector has been designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by governments or by other law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:
    Implant Sciences Corporation
    Company Contact:
    Glenn D. Bolduc
    CEO
    978-752-1700
    Email Contact

    or

    Investor Contact:
    Laurel Moody
    646-810-0608
    Email Contact